Effectiveness and Safety of the Insulin Degludec U100 vs. Glargine U300 in People with Type 1 diabetes-The IneoxPlus Real-World Study

被引：1
|
作者：
De Adana, Maria S. Ruiz, Sr.
Dominguez-Lopez, Marta E.
Mora, Maria Del Rosario Vallejo
Colomo, Natalia
Linares, Francisca
Morillas, Virginia
Herrera, Maria Jose Vallejo
Gallardo, Silvia Patricia Alonso
Fuentes, Maria Teresa Padilla
Vela, Luis I. Navas
Maldonado-Araque, Cristina
Olveira, Gabriel
Martinez, Gemma Rojo
机构：
来源：
DIABETES | 2023年 / 72卷
关键词：
D O I：
10.2337/db23-1803-PUB
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1803-PUB
引用
收藏
页数：2
相关论文
共 50 条
  • [21] A Randomized Controlled Trial Comparing Glargine U300 and Glargine U100 for the Inpatient Management of Medicine and Surgery Patients With Type 2 Diabetes: Glargine U300 Hospital Trial
    Pasquel, Francisco J.
    Lansang, M. Cecilia
    Khowaja, Ameer
    Urrutia, M. Agustina
    Cardona, Saumeth
    Albury, Bonnie
    Galindo, Rodolfo J.
    Fayfman, Maya
    Davis, Georgia
    Migdal, Alexandra
    Vellanki, Priyathama
    Peng, Limin
    Umpierrez, Guillermo E.
    DIABETES CARE, 2020, 43 (06) : 1242 - 1248
  • [22] A Randomized Controlled Trial Comparing Glargine U300 and Glargine U100 for the Inpatient Management of Medicine and Surgery Patients with Type 2 Diabetes: Glargine U300 Hospital Trial
    Pasquel, Francisco J.
    Lansang, M. Cecilia
    Khowaja, Ameer
    Galindo, Rodolfo J.
    Urrutia, Maria A.
    Cardona, Saumeth
    Shakally, Almoutaz
    Lyerla, Ryan C.
    Anzola, Isabel
    Albury, Bonnie S.
    Haw, J. Sonya
    Fayfman, Maya
    Davis, Georgia
    Migdal, Alexandra
    Vellanki, Priyathama
    Peng, Limin
    Umpierrez, Guillermo E.
    DIABETES, 2019, 68
  • [23] Insulin degludec U100 is associated with lower risk for severe and symptomatic hypoglycemia as compared with insulin glargine U100 in subjects with type 1 diabetes
    Tentolouris, Anastasios
    Eleftheriadou, Ioanna
    Tentolouris, Nikolaos
    ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6 (03)
  • [24] Experience after switching from insulin glargine U100 to glargine U300 in patients with type 1 diabetes mellitus. A study after one year of treatment in real life
    Pujante Alarcon, Pedro
    Rodriguez Escobedo, Raul
    Garcia Urruzola, Fernando
    Ares, Jessica
    Manjon, Laura
    Sanchez Ragnarson, Cecilia
    Cacho, Laura
    Delgado, Elias
    Menendez Torre, Edelmiro L.
    ENDOCRINOLOGIA DIABETES Y NUTRICION, 2019, 66 (04): : 210 - 216
  • [25] Insulin glargine u300 versus insulin degludec around spontaneous exercise sessions in people with type 1 diabetes: the Ultraflexi-1 study
    Sourij, H.
    Mueller, A.
    Aberer, F.
    Aziz, F.
    Kojzar, H.
    Sourij, C.
    Obermayer, A.
    Abbas, F.
    Eckstein, M. L.
    Lenz, J.
    Sternad, C.
    Pferschy, P. N.
    Tripolt, N. J.
    Ziko, H.
    Moser, O.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S220 - S221
  • [26] A comparison of Insulin Glargine U300 and Insulin Degludec around spontaneous exercise sessions in people with type 1 diabetes - the ULTRAFLEXI-1 study
    Moser, Othmar
    Mueller, Alexander
    Aberer, Felix
    Aziz, Faisal
    Kojzar, Harald
    Sourij, Caren
    Obermayer, Anna
    Abbas, Farah
    Birnbaumer, Philipp
    Eckstein, Max
    Hoenger, Lukas
    Lenz, Jaqueline
    Mursic, Ines
    Sternad, Christoph
    Weber, Barbara
    Zanker, Matthias
    Ziko, Haris
    Pferschy, Peter
    Tripolt, Norbert
    Sourij, Harald
    WIENER KLINISCHE WOCHENSCHRIFT, 2022, 134 (SUPPL 4) : 251 - 251
  • [27] Improved Glycemic Control with Insulin Glargine 300 U/mL vs. Glargine 100 U/mL in Type 1 Diabetes
    Paola, Lucidi
    Cioli, Patrizia
    Candeloro, Paola
    Andreoli, Anna Marinelli
    Bolli, Geremia B.
    Fanelli, Carmine G.
    Porcellati, Francesca
    DIABETES, 2020, 69
  • [28] Effects of insulin glargine U300 versus insulin degludec U100 on glycemic variability, hypoglycemia, and diet evaluated by continuous glucose monitoring in type 1 diabetes: a retrospective cross-sectional study
    Tsai, Pin-Lun
    Lin, Chia-Hung
    Huang, Yu-Yao
    Chen, Hsin-Yun
    Lin, Yi-Hsuan
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2024, 40 (12): : 1086 - 1094
  • [29] Insulin Glargine U100 Utilization in Patients with Type 2 Diabetes in an Italian Real-World Setting: A Retrospective Study
    Degli Esposti, Luca
    Perrone, Valentina
    Saragoni, Stefania
    Blini, Valerio
    Buda, Stefano
    D'avella, Rosella
    Gasperini, Gina
    Lena, Fabio
    Fanelli, Francesca
    Gazzi, Luca
    Giorgino, Francesco
    JOURNAL OF DIABETES RESEARCH, 2019, 2019
  • [30] Pharmacokinetics, Pharmacodynamics, and Modulation of Hepatic Glucose Production With Insulin Glargine U300 and Glargine U100 at Steady State With Individualized Clinical Doses in Type 1 Diabetes
    Porcellati, Francesca
    Lucidi, Paola
    Candeloro, Paola
    Cioli, Patrizia
    Andreoli, Anna Marinelli
    Curti, Gianluca
    Bolli, Geremia B.
    Fanelli, Carmine G.
    DIABETES CARE, 2019, 42 (01) : 85 - 92
12345